This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Somatic substitution signature as an innovative tool in lung cancer diagnosis
Scientific Reports Open Access 10 October 2019
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 per month
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout

Data availability
Gastric cancers from ref. 3 and colorectal cancers from ref. 4 were analyzed with our framework in our original manuscript2. The new TCGA pan-cancer analysis is based on publicly available GDC calls that can be downloaded from https://portal.gdc.cancer.gov/ (Supplementary Table 1).
References
Balaparya, A. & De, S. Nat. Genet. https://doi.org/10.1038/s41588-018-0219-4 (2018).
Williams, M. J., Werner, B., Barnes, C. P., Graham, T. A. & Sottoriva, A. Nat. Genet. 48, 238–244 (2016).
Wang, K. et al. Nat. Genet. 46, 573–582 (2014).
Sottoriva, A. et al. Nat. Genet. 47, 209–216 (2015).
Aran, D., Sirota, M. & Butte, A. J. Nat. Commun. 6, 8971 (2015).
Forbes, S. A. et al. Nucleic Acids Res. 45 D1, D777–D783 (2017).
Sun, R. et al. Nat. Genet. 49, 1015–1024 (2017).
Andor, N., Harness, J. V., Müller, S., Mewes, H. W. & Petritsch, C. Bioinformatics 30, 50–60 (2014).
Williams, M. J. et al. Nat. Genet. 50, 895–903 (2018).
Burrell, R. A., McGranahan, N., Bartek, J. & Swanton, C. Nature 501, 338–345 (2013).
Acknowledgements
A.S. is supported by the Chris Rokos Fellowship in Evolution and Cancer and by Cancer Research UK (A22909). T.A.G. is supported by Cancer Research UK (A19771). C.P.B. is supported by the Wellcome Trust (097319/Z/11/Z). B.W. is supported by a Geoffrey W. Lewis Post-Doctoral Training fellowship. A.S. and T.A.G. are jointly supported by the Wellcome Trust (202778/B/16/Z and 202778/Z/16/Z, respectively). This work was also supported by Wellcome Trust funding to the Centre for Evolution and Cancer (105104/Z/14/Z).
Author information
Authors and Affiliations
Contributions
M.J.W. performed beta-binomial noise analysis. T.H. performed TCGA classification. All authors participated in the discussion and addressed the critiques. M.J.W., B.W., C.P.B., T.A.G., and A.S. wrote the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figure 1
Supplementary Table
Supplementary Table 1
Rights and permissions
About this article
Cite this article
Williams, M.J., Werner, B., Heide, T. et al. Reply to ‘Revisiting signatures of neutral tumor evolution in the light of complexity of cancer genomic data’. Nat Genet 50, 1628–1630 (2018). https://doi.org/10.1038/s41588-018-0210-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41588-018-0210-0
This article is cited by
-
Neutral syndrome
Nature Human Behaviour (2020)
-
Somatic substitution signature as an innovative tool in lung cancer diagnosis
Scientific Reports (2019)